PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development [Yahoo! Finance]
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
PepGen Inc. (NASDAQ: PEPG) had its price target lowered by analysts at Bank of America Co. from $10.00 to $6.00. They now have a "neutral" rating on the stock.
PepGen Inc. (NASDAQ: PEPG) had its price target lowered by analysts at Wedbush from $19.00 to $12.00. They now have an "outperform" rating on the stock.
PepGen Inc. (NASDAQ: PEPG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.